NDRG2 acts as a PERK co-factor to facilitate PERK branch and ERS-induced cell death

Mei Zhang1, Xiping Liu1,2, Qinhao Wang1

  • 1State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, China.

FEBS Letters
|September 27, 2017
PubMed

Insights

NDRG2 is a tumor suppressor that responds to stress. It acts as a co-factor for the PERK pathway, enhancing endoplasmic reticulum stress-induced apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • NDRG2 (Ndrg family member 2) is a stress-responsive tumor suppressor.
  • Its role in endoplasmic reticulum stress (ERS) response is not well understood.

Discussion:

  • NDRG2 expression is upregulated by ERS inducers like Tg, Tm, and DTT in hepatoma cells.
  • NDRG2 interacts with PERK (protein kinase RNA-like ER kinase), a key component of the unfolded protein response.
  • This interaction enhances PERK pathway signaling, specifically activating downstream ATF4 and CHOP.

Key Insights:

  • NDRG2 acts as a co-factor for the PERK pathway during ERS.
  • NDRG2 facilitates ERS-induced apoptosis, partly mediated by ATF4 and CHOP.
  • This highlights NDRG2's novel role in cellular stress response and cancer biology.

Outlook:

  • Further investigation into NDRG2's precise co-factor mechanism.
  • Exploring therapeutic strategies targeting the NDRG2-PERK axis in cancer.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.8K